Feasibility of Allogeneic Stem Cell Transplantation After Azacitidine in Patients with High Risk Myelodysplastic Syndromes or Low-Blast Count Acute Myeloid Leukemias: the Experience of the BMT-AZA Multicenter Prospective Study

Authors :: Maria Teresa Voso
Francesco Spina
Elisa Cerqui
Carlo Finelli
Alfonso Piciocchi
Agostino Cortelezzi
Stella Santarone
Anna Candoni
Marianna Criscuolo
Giuseppe Leone
Simona Sica
Alfredo Molteni
Flavia Salvi
Luana Fianchi
Antonella Poloni
Matteo Parma
Alessandro Rambaldi
Nicola Cascavilla
Emilio Paolo Alessandrino
Andrea Bacigalupo
Arianna Masciulli
Source :: Clinical Lymphoma Myeloma and Leukemia. 16:S83-S84
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
Myelodysplastic syndromes
Azacitidine
Hematology
Blast Count
medicine.disease
Transplantation
Internal medicine
medicine
In patient
Stem cell
Prospective cohort study
business
Acute myeloid leukemias
medicine.drug

Full Text Access

Tools